$26.850
+0.615 (+2.29%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Apnimed Inc?
Apnimed, Inc. is a good buy right now due to its strong recent performance, with a year-to-date change of +85.69% and a positive analyst outlook, including a target price of $60 from Cantor Fitzgerald. The upcoming FDA decision for its lead product, Oxnimbi, on February 28, 2027, adds a significant potential catalyst for growth. However, the main risk is the regulatory scrutiny associated with the FDA approval process, which could impact the stock negatively.
APMD cerró en $26.85 el Tuesday, tras subir +2.29%
Apnimed Inc (APMD) last closed at $26.85, gaining +2.29%. These facts feed the 1-day and 1-week APMD price prediction above.
Factores de la previsión
Los factores de la previsión de Apnimed Inc (APMD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bullish
Análisis de estacionalidad de APMD
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.